Jani Leinonen, Renowned Finnish Artist, Is Releasing His First NFT on Swappable
Jani Leinonen, the renowned Finnish artist, will offer a 3 day NFT auction of his one-of-one animated artwork titled ‘Things You Own’, on Swappable, until Friday, August 27th at 10am PST. Swappable is a new interface for non-fungible tokens (NFTs) powered by TrustSwap.
Leinonen will be participating in an AMA Ask-Me-Anything event, offering the opportunity for the community to ask him questions.
Leinonen’s first NFT is supported by Stalla Madulain, the renowned Swiss art gallery dating back to 1488 and one of his most ardent supporters. As well as Switzerland-based international fine art logistics and infrastructure provider Haas & Company AG, a reputed partner of art collectors, galleries, museums, and art fairs worldwide which provides custody services for tokenized physical assets.
Swappable, powered by TrustSwap, will create a creative place for artists to sell their artworks and for users to find and collect artworks and digital collectibles. Jeff Kirdeikis, CEO of TrustSwap, mentions: “We are extremely excited to be working with such a renowned artist, we’ve created a platform that reduces the entrance barrier to the NFT space to support creators like Jani Leinonen.”
Leinonen is known for his provocative, yet playful works, criticizing capitalism and consumerism. In 2016, Leinonen was awarded the Finland Prize by the Ministry of Education and Culture, which is given in recognition of a significant career in arts. His work can be found in museums, and in private and public collections on every continent. He is currently exhibiting in Serlachius Museum with the street artist Banksy, and Salo Art Museum. The Five-star hotel Dolder Grand in Zurich has 12 of Leinonen’s works on permanent display. You can find out more about Leinonen on his website.
Jani Leinonen, on his NFT artwork ‘Things you own’: “Have we become more consumers than citizens? Our values, our political views, our emotions, traumas, and our dreams, are revealed by this sacred shopping cart. When we take a look at this portrait of us, how much do we recognize as our own? Will there truly be a new better world displacing the established and old, or will we forever be owned by the things we own?”
The team behind Swappable boasts that the Jani Leinonen collaboration is just the beginning, with many interesting collaborations to be revealed soon.
Swappable is the latest offering from TrustSwap
TrustSwap is a blockchain venture that offers smart contact services and innovative solutions for decentralized finance (DeFi) and commerce to help the crypto community transact with integrity, and accountability. TrustSwap solves problems in the DeFi space connected to tracking and buying crypto with ‘The Crypto App’, split payments, subscriptions, escrow, minting, token locks, and fundraising. TrustSwap is building foundational layers in the rapidly-emerging decentralized finance and commerce landscape with services like The Crypto App, SmartLocks, Mint, Launchpad, and Swappable’s NFT interface. Visit www.trustswap.org for information.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210824005826/en/
Contact information
Howard Pearce
howard@trustswap.org
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kweichow Moutai’s Brand Culture Activities in Greece Foster Sino-Greek Cultural Cooperation21.12.2024 20:41:00 EET | Press release
On December 9th, the exhibition “Longevity in the Tao of Chrysanthemum: The Artistic World of Qi Baishi,” supported by Kweichow Moutai Group, opened at the Athens University History Museum. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241221429801/en/ Gao Shan(R3), and Petros Tatoulis(R2), took a group photo with other guests at the opening ceremony of the exhibition. (Photo: Business Wire) Featuring the works of Qi Baishi, a renowned Chinese painter, the exhibition highlights the unique charm of traditional Chinese culture for Western audiences, while advancing cultural exchange and mutual understanding between China and Greece. Gao Shan, Chairman of the Labor Union at Kweichow Moutai Distillery (Group) Co., Ltd., remarked on the significance of the event, saying, “Qi Baishi employed distinctive Eastern painting techniques to convey the Chinese perspective of the world. Athens, a city celebrated for its great masters and
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 22:46:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 22:35:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 21:32:00 EET | Press release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 14:00:00 EET | Press release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom